Cancer evolution and individual susceptibility.
Cancer susceptibility is due to interactions between inherited genetic factors and exposure to environmental carcinogens. The genetic component is constituted mainly by weakly acting low-penetrance genetic variants that interact among themselves, as well as with the environment. These low susceptibility genes can be categorized into two main groups: one includes those that control intrinsic tumor cell activities (i.e. apoptosis, proliferation or DNA repair), and the other contains those that modulate the function of extrinsic tumor cell compartments (i.e. stroma, angiogenesis, or endocrine and immune systems). Genome-Wide Association Studies (GWAS) of human populations have identified numerous genetic loci linked with cancer risk and behavior, but nevertheless the major component of cancer heritability remains to be explained. One reason may be that GWAS cannot readily capture gene-gene or gene-environment interactions. Mouse model approaches offer an alternative or complementary strategy, because of our ability to control both the genetic and environmental components of risk. Recently developed genetic tools, including high-throughput technologies such as SNP, CGH and gene expression microarrays, have led to more powerful strategies for refining quantitative trait loci (QTL) and identifying the critical genes. In particular, the cross-species approaches will help to refine locations of QTLs, and reveal their genetic and environmental interactions. The identification of human tumor susceptibility genes and discovery of their roles in carcinogenesis will ultimately be important for the development of methods for prediction of risk, diagnosis, prevention and therapy for human cancers.
Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Instituto Mixto Universidad de Salamanca/CSIC, Campus Miguel de Unamuno s/n, Salamanca, 37007, Spain. jperezlosada@usal.es
Jesús
J
Pérez-Losada
Andrés
A
Castellanos-Martín
Jian-Hua
JH
Mao
D000818:Animals; D004198:Disease Susceptibility / Q000139:chemically induced; D004781:Environmental Exposure / Q000009:adverse effects; D055106:Genome-Wide Association Study; D006801:Humans; D009369:Neoplasms / Q000453:epidemiology / Q000235:genetics*; D040641:Quantitative Trait Loci / Q000235:genetics
Nat Genet. 1999 Oct;23(2):237-40
10508525
Cancer Treat Res. 1991;53:335-64
1672086
Immunol Today. 1991 May;12(5):143-6
1878124
Trends Genet. 2005 Dec;21(12):683-92
16226337
Cell. 2010 Apr 16;141(2):210-7
20403315
Annu Rev Genet. 2008;42:131-41
18759635
Genome Res. 2004 Sep;14(9):1767-72
15310659
Nat Rev Cancer. 2007 Nov;7(11):834-46
17957189
Genome Res. 2003 Jan;13(1):118-21
12529314
Nature. 2009 Mar 26;458(7237):505-8
19136944
Nat Genet. 2007 Aug;39(8):989-94
17618283
J Natl Compr Canc Netw. 2007 Sep;5(8):711-718
17927928
PLoS Genet. 2007 Nov;3(11):e214
18081427
Nat Genet. 2004 Nov;36(11):1197-202
15489855
Cancer Res. 2001 Feb 15;61(4):1305-8
11245425
J Mammary Gland Biol Neoplasia. 2008 Sep;13(3):337-42
18661105
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4340-5
18326623
Cell. 2010 Apr 2;141(1):39-51
20371344
Ann Oncol. 2008 Oct;19(10):1665-7
18809584
Anim Genet. 2006 Aug;37 Suppl 1:7-9
16886995
Trends Genet. 1998 Apr;14(4):139-44
9594661
Trends Genet. 2005 Jul;21(7):373-6
15913834
Nat Genet. 2004 Nov;36(11):1133-7
15514660
Breast Cancer Res. 2007;9(6):114
18096087
Nat Genet. 2007 Aug;39(8):984-8
17618284
Nat Rev Genet. 2005 Apr;6(4):271-86
15803197
Am J Epidemiol. 2009 Aug 1;170(3):269-79
19498075
Cell. 2007 Apr 20;129(2):235
17448981
Cell. 2010 Aug 6;142(3):351-3; author reply 353-5
20691891
Nat Genet. 2000 Aug;25(4):381-4
10932178
Breast Cancer Res. 2006;8(2):R16
16563182
Cell. 2010 Apr 2;141(1):52-67
20371345
Cell. 1995 Jun 16;81(6):957-66
7781071
Int J Cancer. 2002 May 10;99(2):260-6
11979442
Am J Hum Genet. 1998 Jul;63(1):45-51
9634504
Front Biosci (Elite Ed). 2010 Jan 01;2:122-6
20036861
Eur J Clin Invest. 2002 Jun;32(6):383-93
12059982
Nat Genet. 2003 Aug;34(4):403-12
12881723
Sci Transl Med. 2009 Nov 18;1(7):7ps8
20368180
N Engl J Med. 1986 Dec 25;315(26):1650-9
3537791
Trends Genet. 2010 Mar;26(3):132-41
20106545
J Cell Sci. 2004 Mar 15;117(Pt 8):1287-90
15020668
Eur J Surg Oncol. 2003 Jun;29(5):475-9
12798754
Carcinogenesis. 2005 Aug;26(8):1368-73
15802297
Mamm Genome. 2008 Jun;19(6):379-81
18521666
Nat Genet. 2001 Nov;29(3):306-9
11600885
Cancer. 1994 Aug 1;74(3 Suppl):1101-10
8039145
PLoS One. 2009 Aug 10;4(8):e6562
19668347
Methods. 2011 Feb;53(2):163-74
20643209
Nature. 2005 Dec 8;438(7069):803-19
16341006
Nature. 2009 Oct 22;461(7267):1084-91
19847259
Cell. 2002 Jan 25;108(2):145-52
11832205
N Engl J Med. 2000 Jul 13;343(2):78-85
10891514
Nat Genet. 2003 Mar;33 Suppl:238-44
12610533
Nat Genet. 2008 Jun;40(6):703-6
18438407
Nat Genet. 2008 Aug;40(8):955-62
18587394
Nature. 2005 Sep 1;437(7055):69-87
16136131
Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):964-72
18361430
Cancer Res. 1999 Oct 1;59(19):5002-11
10519415
Circ Res. 2005 Jan 7;96(1):27-42
15637305
Nat Genet. 2005 Nov;37(11):1181-6
16254564
Nat Genet. 2006 Aug;38(8):926-30
16823377
Nature. 2007 Jun 28;447(7148):1087-93
17529967
Genes Brain Behav. 2002 Nov;1(4):214-22
12882366
Nature. 2007 Aug 30;448(7157):1050-3
17660834
Nat Rev Cancer. 2009 Apr;9(4):239-52
19279573
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16203-8
12456890
Nat Genet. 2007 Jul;39(7):870-4
17529973
Am J Med Sci. 2011 Mar;341(3):227-31
20460980
Science. 1996 Sep 13;273(5281):1516-7
8801636
Nature. 1995 Dec 21-28;378(6559):789-92
8524414
Nat Rev Cancer. 2003 Jun;3(6):434-43
12778133
Cancer Res. 1998 Nov 1;58(21):4794-8
9809979
Carcinogenesis. 2000 Mar;21(3):371-7
10688857
BMC Med Genet. 2007 Sep 19;8 Suppl 1:S6
17903305
Nat Genet. 2009 May;41(5):579-84
19330030
Nat Genet. 2009 Mar;41(3):324-8
19219042
Science. 1994 Oct 7;266(5182):120-2
7939630
Nat Genet. 1995 Aug;10(4):424-9
7670492
Nat Genet. 2009 May;41(5):585-90
19330027
Cancer Cell. 2007 Feb;11(2):103-5
17292821
Am J Hum Genet. 2000 Dec;67(6):1367-75
11067781
Anticancer Res. 1998 May-Jun;18(3B):2095-9
9677474
Nat Genet. 2008 Jan;40(1):17-22
18163131
Nature. 2002 Dec 19-26;420(6917):860-7
12490959
Science. 2001 Feb 16;291(5507):1304-51
11181995
Nat Rev Genet. 2009 Sep;10(9):651-7
19636343
Nat Genet. 2007 Jul;39(7):865-9
17529974
Nat Rev Genet. 2001 Jan;2(1):11-20
11253063
Carcinogenesis. 2003 Jun;24(6):1143-8
12807761
J Investig Dermatol Symp Proc. 1997 Aug;2(1):61-8
9487018
Nat Genet. 2002 Nov;32(3):355-7
12379854
Mamm Genome. 2003 Nov;14(11):733-47
14722723
Nat Genet. 2002 May;31(1):55-9
11967536
Expert Rev Mol Diagn. 2010 May;10(4):509-19
20465505
Adv Genet. 2008;60:51-74
18358316
Endocr Relat Cancer. 2007 Dec;14(4):907-33
18045947
Nature. 2001 Feb 15;409(6822):860-921
11237011
Genetics. 2002 Apr;160(4):1609-18
11973314
Nat Genet. 1996 Dec;14(4):468-70
8944029
Trends Genet. 2001 Jul;17(7):388-91
11418218
Cell. 2010 Aug 6;142(3):350-1; author reply 353-5
20691890
N Engl J Med. 2001 Mar 15;344(11):783-92
11248153
Cancer Treat Res. 2010;155:85-103
20517689
Lancet. 2010 Jun 19;375(9732):2143-51
20605201
Genet Epidemiol. 2008 Feb;32(2):179-85
18200594
J Natl Cancer Inst. 2009 Jul 15;101(14):1012-8
19567422
Cancer Metastasis Rev. 2010 Jun;29(2):309-16
20405169
Nat Rev Genet. 2009 Apr;10(4):241-51
19293820
Nat Med. 2001 May;7(5):552-6
11329055
Cancer Res. 2003 Dec 1;63(23):8153-7
14678969
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8685-90
17502601
Am J Hum Genet. 2009 Feb;84(2):115-22
19147119
CA Cancer J Clin. 2006 May-Jun;56(3):168-83
16737949
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15032-7
10611333
Nature. 2002 Dec 5;420(6915):520-62
12466850
Oncogene. 2004 May 27;23(25):4495-504
15064703